AIMS: The Brugada syndrome (BrS) is an inherited cardiac disorder predisposing to ventricular arrhythmias. Despite considerable efforts, its genetic basis and cellular mechanisms remain largely unknown. The objective of this study was to identify a new susceptibility gene for BrS through familial investigation. METHODS AND RESULTS: Whole-exome sequencing performed in a three-generation pedigree with five affected members allowed the identification of one rare non-synonymous substitution (p.R211H) in RRAD, the gene encoding the RAD GTPase, carried by all affected members of the family. Three additional rare missense variants were found in 3/186 unrelated index cases. We detected higher levels of RRAD transcripts in subepicardium than in subendocardium in human heart, and in the right ventricle outflow tract compared to the other cardiac compartments in mice. The p.R211H variant was then subjected to electrophysiological and structural investigations in human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs). Cardiomyocytes derived from induced pluripotent stem cells from two affected family members exhibited reduced action potential upstroke velocity, prolonged action potentials and increased incidence of early afterdepolarizations, with decreased Na+ peak current amplitude and increased Na+ persistent current amplitude, as well as abnormal distribution of actin and less focal adhesions, compared with intra-familial control iPSC-CMs Insertion of p.R211H-RRAD variant in control iPSCs by genome editing confirmed these results. In addition, iPSC-CMs from affected patients exhibited a decreased L-type Ca2+ current amplitude. CONCLUSION: This study identified a potential new BrS-susceptibility gene, RRAD. Cardiomyocytes derived from induced pluripotent stem cells expressing RRAD variant recapitulated single-cell electrophysiological features of BrS, including altered Na+ current, as well as cytoskeleton disturbances. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The Brugada syndrome (BrS) is an inherited cardiac disorder predisposing to ventricular arrhythmias. Despite considerable efforts, its genetic basis and cellular mechanisms remain largely unknown. The objective of this study was to identify a new susceptibility gene for BrS through familial investigation. METHODS AND RESULTS: Whole-exome sequencing performed in a three-generation pedigree with five affected members allowed the identification of one rare non-synonymous substitution (p.R211H) in RRAD, the gene encoding the RAD GTPase, carried by all affected members of the family. Three additional rare missense variants were found in 3/186 unrelated index cases. We detected higher levels of RRAD transcripts in subepicardium than in subendocardium in human heart, and in the right ventricle outflow tract compared to the other cardiac compartments in mice. The p.R211H variant was then subjected to electrophysiological and structural investigations in human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs). Cardiomyocytes derived from induced pluripotent stem cells from two affected family members exhibited reduced action potential upstroke velocity, prolonged action potentials and increased incidence of early afterdepolarizations, with decreased Na+ peak current amplitude and increased Na+ persistent current amplitude, as well as abnormal distribution of actin and less focal adhesions, compared with intra-familial control iPSC-CMs Insertion of p.R211H-RRAD variant in control iPSCs by genome editing confirmed these results. In addition, iPSC-CMs from affected patients exhibited a decreased L-type Ca2+ current amplitude. CONCLUSION: This study identified a potential new BrS-susceptibility gene, RRAD. Cardiomyocytes derived from induced pluripotent stem cells expressing RRAD variant recapitulated single-cell electrophysiological features of BrS, including altered Na+ current, as well as cytoskeleton disturbances. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Christiaan C Veerman; Svitlana Podliesna; Rafik Tadros; Elisabeth M Lodder; Isabella Mengarelli; Berend de Jonge; Leander Beekman; Julien Barc; Ronald Wilders; Arthur A M Wilde; Bastiaan J Boukens; Ruben Coronel; Arie O Verkerk; Carol Ann Remme; Connie R Bezzina Journal: Circ Res Date: 2017-06-21 Impact factor: 17.367
Authors: B Risgaard; R Jabbari; L Refsgaard; A G Holst; S Haunsø; A Sadjadieh; B G Winkel; M S Olesen; J Tfelt-Hansen Journal: Clin Genet Date: 2013-03-11 Impact factor: 4.438
Authors: Yasuhiko Sakata; Caramai N Kamei; Hironori Nakagami; Roderick Bronson; James K Liao; Michael T Chin Journal: Proc Natl Acad Sci U S A Date: 2002-11-26 Impact factor: 11.205
Authors: Jonathan Satin; Ilanit Itzhaki; Sophia Rapoport; Elizabeth A Schroder; Leighton Izu; Gil Arbel; Rafael Beyar; C William Balke; Jackie Schiller; Lior Gepstein Journal: Stem Cells Date: 2008-05-15 Impact factor: 6.277
Authors: Antoine Andorin; Elijah R Behr; Isabelle Denjoy; Lia Crotti; Federica Dagradi; Laurence Jesel; Fréderic Sacher; Bertrand Petit; Philippe Mabo; Alice Maltret; Leonie C H Wong; Bruno Degand; Géraldine Bertaux; Philippe Maury; Yves Dulac; Béatrice Delasalle; Jean-Baptiste Gourraud; Dominique Babuty; Nico A Blom; Peter J Schwartz; Arthur A Wilde; Vincent Probst Journal: Heart Rhythm Date: 2016-02-24 Impact factor: 6.343
Authors: Guoxia Liu; Arianne Papa; Alexander N Katchman; Sergey I Zakharov; Daniel Roybal; Jessica A Hennessey; Jared Kushner; Lin Yang; Bi-Xing Chen; Alexander Kushnir; Katerina Dangas; Steven P Gygi; Geoffrey S Pitt; Henry M Colecraft; Manu Ben-Johny; Marian Kalocsay; Steven O Marx Journal: Nature Date: 2020-01-22 Impact factor: 49.962